TipRanks Cyber Monday Sale
- Claim 60% off TipRanks Premium for data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Aarti Drugs Limited ( (IN:AARTIDRUGS) ) has issued an update.
Aarti Drugs Limited has released its Business Responsibility and Sustainability Report for the financial year 2024-25. This report, which aligns with SEBI’s listing regulations, highlights the company’s commitment to sustainable business practices and is available on their website. The report underscores Aarti Drugs’ dedication to responsible business operations, which could enhance its market positioning and stakeholder relations.
More about Aarti Drugs Limited
Aarti Drugs Limited is a company operating in the pharmaceuticals industry, primarily engaged in the manufacturing and marketing of pharmaceuticals and chemical products. The company’s main products include Active Pharmaceutical Ingredients (APIs), specialty chemicals, and intermediates, contributing significantly to its turnover.
Average Trading Volume: 33,129
Technical Sentiment Signal: Buy
Current Market Cap: 42.85B INR
For a thorough assessment of AARTIDRUGS stock, go to TipRanks’ Stock Analysis page.